Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma
Work
Year: 2021
Type: article
Abstract: Purpose: Neoadjuvant immunotherapy may improve the clinical outcome of regionally advanced operable melanoma and allows for rapid clinical and pathologic assessment of response. We examined neoadjuva... more
Source: Clinical Cancer Research
Institutions UPMC Hillman Cancer Center, University of Pittsburgh, Penn State Milton S. Hershey Medical Center, Parker Institute for Cancer Immunotherapy, University of California, San Francisco +2 more
Cites: 43
Cited by: 19
Related to: 10
FWCI: 1.927
Citation percentile (by year/subfield): 83.45
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Sustainable Development Goal Good health and well-being
Open Access status: bronze